Sino Biopharmaceutical Ltd (SBHMY)
7.20
0.00 (0.00%)
USD |
OTCM |
May 03, 16:00
Sino Biopharmaceutical Debt to Equity Ratio: 0.4007 for Dec. 31, 2023
Debt to Equity Ratio Chart
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| December 31, 2023 | 0.4007 |
| June 30, 2023 | 0.373 |
| December 31, 2022 | 0.4571 |
| Date | Value |
|---|---|
| June 30, 2022 | 0.3843 |
| December 31, 2009 | 0.0005 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
0.373
Minimum
Jun 2023
0.4571
Maximum
Dec 2022
0.4038
Average
0.3925
Median
Debt to Equity Ratio Benchmarks
| HUTCHMED (China) Ltd | 0.1086 |
| Pharmaron Beijing Co Ltd | 0.4949 |
| Regencell Bioscience Holdings Ltd | -- |
| Prenetics Global Ltd | 0.00 |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 8.973B |
| Total Liabilities (Quarterly) | 3.588B |
| Shareholders Equity (Quarterly) | 4.299B |
| Current Ratio | 1.053 |
| Net Debt Paydown Yield | 0.04% |